{"id":55792,"date":"2025-03-08T19:43:36","date_gmt":"2025-03-08T11:43:36","guid":{"rendered":"http:\/\/www.newtopchem.com\/archives\/55792"},"modified":"2025-03-08T19:43:36","modified_gmt":"2025-03-08T11:43:36","slug":"biocompatibility-of-reactive-gel-catalysts-in-medical-implants","status":"publish","type":"post","link":"http:\/\/www.newtopchem.com\/archives\/55792","title":{"rendered":"Biocompatibility of reactive gel catalysts in medical implants","gt_translate_keys":[{"key":"rendered","format":"text"}]},"content":{"rendered":"
With the continuous advancement of medical technology, medical implants are becoming more and more widely used in clinical practice. From cardiac stents to artificial joints, medical implants have become an important means of treating a variety of diseases. However, biocompatibility issues of implants have been the focus of attention in the medical community. As a new material, reactive gel catalysts are gradually emerging in the field of medical implants due to their unique physicochemical properties and biocompatible. This article will introduce in detail the application of reactive gel catalysts in medical implants and their biocompatibility. <\/p>\n
Reactive gel catalyst is a catalytically active gel material that can induce or accelerate chemical reactions under certain conditions. Unlike traditional catalysts, reactive gel catalysts not only have catalytic functions, but also have good biocompatibility and degradability, so they have broad application prospects in the medical field. <\/p>\n
Reactive gel catalysts are usually composed of the following parts:<\/p>\n
There are many methods for preparing reactive gel catalysts, and the common ones are:<\/p>\n
Cardous stents are an important tool for the treatment of coronary artery disease. Although traditional metal stents can effectively support blood vessels, they are prone to restenosis and thrombosis after long-term implantation. Reactive coagulationThe glue-catalyst-coated cardiac stent is able to release drugs through catalytic reactions, inhibiting endovascular hyperplasia and thrombosis. <\/p>\n
parameter name<\/th>\n | parameter value<\/th>\n<\/tr>\n | ||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Matrix Material<\/td>\n | Polylactic acid (PLA)<\/td>\n<\/tr>\n | ||||||||||||||||||||||||
Catalyzer<\/td>\n | Metal ions (such as zinc ions)<\/td>\n<\/tr>\n | ||||||||||||||||||||||||
Crosslinker<\/td>\n | Polyethylene glycol (PEG)<\/td>\n<\/tr>\n | ||||||||||||||||||||||||
Drug release time<\/td>\n | 30 days<\/td>\n<\/tr>\n | ||||||||||||||||||||||||
Biodegradation time<\/td>\n | 6-12 months<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\nArtificial joint<\/h3>\nArthroplasty is an effective method for treating severe joint diseases. Although traditional artificial joint materials such as titanium alloys and polyethylene have good mechanical properties, they are prone to inflammation and wear after long-term use. Artificial joints coated with reactive gel catalysts are able to release anti-inflammatory drugs through catalytic reactions, reducing inflammatory reactions and wear. <\/p>\n Product Parameters<\/h4>\n
|